BiotechTube
Evidenze

Evidenze

Barcelona, Spain· Est.
evidenze.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $1.2M

Overview

Evidenze is a Spain-based, technology-enabled Contract Research Organization (CRO) that has rapidly established a global presence since its 2018 founding. It differentiates itself from traditional CROs through a 'Full Value' proposition, which integrates strategic consulting, regulatory expertise, and proprietary digital tools—such as eClinical platforms and data science capabilities—into its core clinical trial services. The company targets the growing demand for efficient, data-driven clinical research from biotech and small-to-medium pharmaceutical sponsors, aiming to accelerate study timelines and maximize the impact of clinical evidence.

Oncology

Technology Platform

Integrated suite of eClinical and data science tools including eCRF, ePRO/eDiary, eTMF/eISF, eConsent, eRND, IWRS, and advanced data management/biostatistics software for automated, data-driven clinical trial execution.

Funding History

1
Total raised:$1.2M
Seed$1.2M

Opportunities

The growing reliance of biotech and small-to-medium pharma on outsourcing, combined with the industry-wide shift towards digitalized and decentralized trials, creates a strong demand for technology-integrated CRO services.
Evidenze's 'Full Value' positioning allows it to target sponsors seeking strategic partners to maximize trial impact and data utility for regulatory and commercial success.

Risk Factors

Intense competition from large global CROs and niche players requires clear and proven differentiation.
The business is highly dependent on human capital retention and consistent technology execution.
Revenue is project-based and can be volatile, subject to client budget cycles and competitive bidding losses.

Competitive Landscape

Evidenze competes in the fragmented global CRO market against large players (e.g., IQVIA, ICON, LabCorp) with vast resources and broad portfolios, as well as numerous small-to-mid-sized CROs. Its differentiation hinges on combining senior-led therapeutic expertise with a proprietary digital platform, targeting sponsors who value a strategic, technology-forward partnership over pure scale.

More companies in Digital Health & Biotech SaaS →More companies in Spain →